Enbiosis
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Enbiosis focuses on producing scientific inventions, products, and services by using microbiome organisms.
HQ Location
United Kingdom
Founded
2019
Employees
11 - 50
Total funding raised
$2.07M
Last Funding Event
Seed, $2.07M, May 1, 2021
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of artificial intelligence algorithm analyzing biotechnology intended to improve the quality of human health. The company's technology specializes in combining artificial intelligence and microbiome science to analyze the human gut microbiome to provide personalized health, which covers a special diet program and prebiotics, enabling people to reach deep into their inner world with the microbiome and stay healthy with diet.